2023년 5월 17일 16:52

Next&Bio Signs MOU with Cancer Science Institute of Singapore for Organoid Collaboration

Next&Bio Inc. (Co-CEO: HyunSook Lee, Ji-Hun Yang), a company that has developed an organoid-based precision medicine drug discovery and development platform, has signed a memorandum of understanding (MOU) with the Cancer Science Institute of Singa...

건강제약의학제휴